These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15963292)

  • 1. Macrolide- and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003.
    Malhotra-Kumar S; Lammens C; Chapelle S; Wijdooghe M; Piessens J; Van Herck K; Goossens H
    Emerg Infect Dis; 2005 Jun; 11(6):939-42. PubMed ID: 15963292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.
    Mazzariol A; Koncan R; Bahar G; Cornaglia G
    J Chemother; 2007 Oct; 19(5):500-7. PubMed ID: 18073148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Declining macrolide resistance in Streptococcus pyogenes in Portugal (2007-13) was accompanied by continuous clonal changes.
    Silva-Costa C; Ramirez M; Melo-Cristino J;
    J Antimicrob Chemother; 2015 Oct; 70(10):2729-33. PubMed ID: 26142474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptococcus pyogenes isolates with high-level macrolide resistance and reduced susceptibility to telithromycin associated with 23S rRNA mutations.
    Farrell DJ; Shackcloth J; Barbadora KA; Green MD
    Antimicrob Agents Chemother; 2006 Feb; 50(2):817-8. PubMed ID: 16436755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to macrolides, clindamycin and telithromycin in Streptococcus pyogenes isolated in Spain during 2004.
    Tamayo J; Pérez-Trallero E; Gómez-Garcés JL; Alós JI;
    J Antimicrob Chemother; 2005 Oct; 56(4):780-2. PubMed ID: 16120627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
    Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
    Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolide-resistant genes of Streptococcus pyogenes isolated from the upper respiratory tract by polymerase chain reaction.
    Billal DS; Hotomi M; Yamauchi K; Fujihara K; Tamura S; Kuki K; Sugita R; Endou M; Mukaigawa J; Yamanaka N
    J Infect Chemother; 2004 Apr; 10(2):115-20. PubMed ID: 15160306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States.
    Green M; Allen C; Bradley J; Dashefsky B; Gilsdorf JR; Marcon MJ; Schutze GE; Smith C; Walter E; Martin JM; Edwards KA; Barbadora KA; Rumbaugh RM; Wald ER
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2487-9. PubMed ID: 15917551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of macrolide-resistant Streptococcus pyogenes strains in French children.
    Bingen E; Bidet P; Mihaila-Amrouche L; Doit C; Forcet S; Brahimi N; Bouvet A; Cohen R
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3559-62. PubMed ID: 15328126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What causes decreased erythromycin resistance in Streptococcus pyogenes? Dynamics of four clones in a southern European region from 2005 to 2012.
    Montes M; Tamayo E; Mojica C; García-Arenzana JM; Esnal O; Pérez-Trallero E
    J Antimicrob Chemother; 2014 Jun; 69(6):1474-82. PubMed ID: 24562616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 5-day therapy with telithromycin, a novel ketolide antibacterial, for the treatment of tonsillopharyngitis.
    Norrby SR; Quinn J; Rangaraju M; Leroy B
    Clin Microbiol Infect; 2004 Jul; 10(7):615-23. PubMed ID: 15214873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of macrolide and tetracycline resistance mechanisms in Streptococcus pyogenes isolates and in vitro susceptibility to telithromycin.
    Betriu C; Culebras E; Redondo M; Rodríguez-Avial I; Gómez M; Boloix A; Picazo JJ
    J Antimicrob Chemother; 2002 Sep; 50(3):436-8. PubMed ID: 12205076
    [No Abstract]   [Full Text] [Related]  

  • 14. Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin.
    Morosini MI; Cantón R; Loza E; del Campo R; Almaraz F; Baquero F
    J Antimicrob Chemother; 2003 Jul; 52(1):50-5. PubMed ID: 12805254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany.
    Bley C; van der Linden M; Reinert RR
    Int J Antimicrob Agents; 2011 May; 37(5):425-31. PubMed ID: 21419605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of Streptococcus pyogenes macrolide resistance of paediatric isolates during a 7 year period (2007-13).
    Michos A; Koutouzi FI; Tsakris A; Chatzichristou P; Koutouzis EI; Daikos GL; Stathi A; Syriopoulou VP
    J Antimicrob Chemother; 2016 Aug; 71(8):2113-7. PubMed ID: 27118782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and characterization of macrolide resistance in clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes from North America.
    Hoban DJ
    J Chemother; 2002 Jul; 14 Suppl 3():25-30. PubMed ID: 12418558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002.
    Szczypa K; Sadowy E; Izdebski R; Hryniewicz W
    J Antimicrob Chemother; 2004 Oct; 54(4):828-31. PubMed ID: 15329367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptococcus pneumoniae and Streptococcus pyogenes isolated from a paediatric population in Great Britain and Ireland: the in vitro activity of telithromcycin versus comparators.
    Shackcloth J; Williams L; Farrell DJ
    J Infect; 2004 Apr; 48(3):229-35. PubMed ID: 15001301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of antimicrobial susceptibility of clinical isolates of Streptococcus pyogenes in Japan: report of a countrywide surveillance study.
    Hotomi M; Billal DS; Shimada J; Yamauchi K; Fujihara K; Yamanaka N;
    J Infect Chemother; 2005 Feb; 11(1):48-51. PubMed ID: 15729489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.